| An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies |
| Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression |
| Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants |
| Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations |
| A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies |
| Comprehensive DNA methylation analysis indicates that pancreatic intraepithelial neoplasia lesions are acinar-derived and epigenetically primed for carcinogenesis |
| Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism |
| Pervasiveness of HLA allele-specific expression loss across tumor types |
| Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma |
| Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices |
| Cysteine depletion induces pancreatic tumor ferroptosis in mice |
| Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response |
| Effective delivery of a microtubule polymerization inhibitor synergizes with standard regimens in models of pancreatic ductal adenocarcinoma |
| Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes |
| Laser Capture Microdissection on Frozen Sections for Extraction of High-Quality Nucleic Acids |
| Comprehensive characterisation of compartmentspecific long non-coding RNAs associated with pancreatic ductal adenocarcinoma |
| Elasticity mapping of murine abdominal organs in vivo using Harmonic Motion Imaging (HMI) |
| Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma |
| Translational Therapeutics in Genetically Engineered Mouse Models of Cancer |
| Acquisition of Mouse Tumor Biopsies through Abdominal Laparotomy |
| Identification and Manipulation of Biliary Metaplasia in Pancreatic Tumors |
| Pancreatic cancer: why is it so hard to treat? |
| Recapitulating human cancer in a mouse |
| Quantification of Murine Pancreatic Tumors by High Resolution Ultrasound |
| Genetically Engineered Mouse Models of Pancreatic Cancer |
| Silencing the Killers: Paracrine Immune Suppression in Pancreatic Cancer |
| A novel method for quantiWcation of gemcitabine and its metabolites 2,2-diXuorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy |
| Stromal biology and therapy in pancreatic cancer |
| Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer |
| Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer |
| Heterozygosity for Hypoxia Inducible Factor 1α decreases the incidence of thymic lymphomas in a p53 mutant mouse model |
| K-Ras-Driven Pancreatic Cancer Mouse Model for Anticancer Inhibitor Analyses |
| The Use of Targeted Mouse Models for Preclinical Testing of Novel Cancer Therapeutics |
| The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung Cancer |
| Mice Expressing a Mammary Gland-Specific R270H Mutation in the p53 Tumor Suppressor Gene Mimic Human Breast Cancer Development |
| Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome |
